Ziegler Capital Management’s AstraZeneca AZN Stock Holding History

Ziegler Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.47M	Sell	10,839 -530	-5%	-$70.2K	0.06%	233
2023 Q4	$1.54M	Sell	11,369 -409	-3%	-$53.2K	0.07%	243
2023 Q3	$1.6M	Sell	11,778 -348	-3%	-$47.5K	0.06%	237
2023 Q2	$1.74M	Sell	12,126 -2,725	-18%	-$401K	0.07%	243
2023 Q1	$2.1M	Sell	14,851 -113	-0.8%	-$15.2K	0.08%	217
2022 Q4	$2.05M	Sell	14,964 -175	-1%	-$21.9K	0.09%	213
2022 Q3	$1.66M	Sell	15,139 -133	-0.9%	-$16.9K	0.07%	220
2022 Q2	$2.02M	Sell	15,272 -346	-2%	-$45.4K	0.08%	214
2022 Q1	$2.07M	Buy	15,618 +3,851	+33%	+$462K	0.09%	208
2021 Q4	$1.37M	Sell	11,767 -618	-5%	-$72.7K	0.05%	280
2021 Q3	$1.49M	Buy	+12,385	New	+$1.44M	0.05%	296
2020 Q2	–	Sell	-28,637	Closed	-$2.56M	–	436
2020 Q1	$2.56M	Buy	+28,637	New	+$2.7M	0.07%	268
2013 Q3	$2.64M	Buy	50,900 +900	+2%	+$45.2K	0.23%	132
2013 Q2	$2.37M	Buy	+50,000	New	+$2.55M	0.25%	115

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ziegler Capital Management's AZN Position: Q1 2024 in Review

Ziegler Capital Management reduced its AstraZeneca (AZN) stake by 4.7% in Q1 2024, selling an estimated $70.2K and leaving 10,839 shares worth $1.47M. The position accounts for 0.06% of the portfolio, ranked #233.

Ziegler Capital Management first reported a position in AZN in Q2 2013 and has held it in 14 quarters since. The position peaked at $2.64M in Q3 2013. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

Ziegler Capital Management held 10,839 shares of AstraZeneca worth $1.47M as of Q1 2024.
Ziegler Capital Management sold 530 AstraZeneca shares in Q1 2024, an estimated $70.2K.
AstraZeneca made up 0.06% of Ziegler Capital Management's portfolio in Q1 2024, its #233 holding.
Ziegler Capital Management first reported a position in AstraZeneca in Q2 2013 and has held it in 14 quarters since.
Ziegler Capital Management's AstraZeneca position peaked at $2.64M in Q3 2013.
1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.